CSPIA
EW icon

Cary Street Partners Investment Advisory’s Edwards Lifesciences EW Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$173K Buy
1,911
+413
+28% +$34.6K 0.04% 404
2026
Q1 		$120K Buy
1,498
+57
+4% +$4.7K 0.03% 430
2025
Q4 		$123K Buy
1,441
+114
+9% +$9.36K 0.03% 400
2025
Q3 		$103K Sell
1,327
-244
-16% -$19.1K 0.04% 360
2025
Q2 		$123K Buy
1,571
+537
+52% +$40K 0.06% 305
2025
Q1 		$74.9K Buy
1,034
+431
+71% +$30.8K 0.04% 328
2024
Q4 		$44.6K Sell
603
-5,482
-90% -$384K 0.03% 328
2024
Q3 		$402K Buy
6,085
+42
+0.7% +$3.05K 0.01% 544
2024
Q2 		$558K Buy
6,043
+203
+3% +$18K 0.02% 447
2024
Q1 		$558K Buy
5,840
+431
+8% +$36.2K 0.02% 438
2023
Q4 		$412K Buy
5,409
+627
+13% +$43.6K 0.02% 455
2023
Q3 		$331K Buy
4,782
+1,099
+30% +$88.3K 0.02% 460
2023
Q2 		$347K Hold
3,683
– – 0.02% 410
2023
Q1 		$305K Sell
3,683
-100
-3% -$7.86K 0.02% 405
2022
Q4 		$282K Sell
3,783
-50
-1% -$3.85K 0.02% 408
2022
Q3 		$317K Buy
3,833
+1,355
+55% +$130K 0.03% 380
2022
Q2 		$236K Buy
+2,478
New +$257K 0.02% 395
2020
Q4 		– Sell
-240
Closed -$19K – 512
2020
Q3 		$19K Buy
+240
New +$18.7K ﹤0.01% 665

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Cary Street Partners Investment Advisory's EW Position: Q2 2026 in Review

Cary Street Partners Investment Advisory increased its Edwards Lifesciences (EW) stake by 28% in Q2 2026, buying an estimated $34.6K and bringing the position to 1,911 shares worth $173K. The position accounts for 0.04% of the portfolio, ranked #404.

Cary Street Partners Investment Advisory first reported a position in EW in Q3 2020 and has held it in 18 quarters since. The position peaked at $558K in Q2 2024. 1,057 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Cary Street Partners Investment Advisory held 1,911 shares of Edwards Lifesciences worth $173K as of Q2 2026.
  • Cary Street Partners Investment Advisory bought 413 Edwards Lifesciences shares in Q2 2026, an estimated $34.6K.
  • Edwards Lifesciences made up 0.04% of Cary Street Partners Investment Advisory's portfolio in Q2 2026, its #404 holding.
  • Cary Street Partners Investment Advisory first reported a position in Edwards Lifesciences in Q3 2020 and has held it in 18 quarters since.
  • Cary Street Partners Investment Advisory's Edwards Lifesciences position peaked at $558K in Q2 2024.
  • 1,057 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2026, filed 17 Jul 2026.